Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong
· Delayed Price · Currency is HKD 29.78
+0.38 (1.29%)
Apr 29, 2026, 4:08 PM HKT
Giant Biogene Holding Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | - | 2,062 | 1,452 | 1,002 | 828.13 | Upgrade
|
| Depreciation & Amortization | - | 48.98 | 33.69 | 27.24 | 23.94 | Upgrade
|
| Other Amortization | - | 0.51 | 0.48 | 0.39 | 0.27 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.56 | 2.88 | 2.91 | 0.18 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -43.27 | -29.33 | 8.28 | -14.47 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 3.6 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 89.72 | 20.52 | 17.66 | 16.49 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.94 | -0.03 | -0.15 | 0.05 | Upgrade
|
| Other Operating Activities | - | -94.83 | 39.65 | 4.94 | -104.34 | Upgrade
|
| Change in Accounts Receivable | - | -40.2 | -32.58 | -3.64 | -11.16 | Upgrade
|
| Change in Inventory | - | -113.51 | -17.77 | -94.36 | -24.61 | Upgrade
|
| Change in Accounts Payable | - | 153.6 | 78.46 | 31.04 | -8.33 | Upgrade
|
| Change in Unearned Revenue | - | -19.22 | 24.7 | -3.23 | 13.54 | Upgrade
|
| Change in Other Net Operating Assets | - | -6.92 | 75.01 | -61.49 | -27.28 | Upgrade
|
| Operating Cash Flow | - | 2,041 | 1,647 | 931.64 | 692.4 | Upgrade
|
| Operating Cash Flow Growth | - | 23.90% | 76.83% | 34.55% | -16.99% | Upgrade
|
| Capital Expenditures | - | -246.77 | -226.3 | -152.66 | -75 | Upgrade
|
| Divestitures | - | -3.69 | 33.13 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.01 | -2.13 | -0.59 | -0.13 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | - | - | -19.53 | Upgrade
|
| Investment in Securities | - | -967 | -379.47 | -718.65 | 1,447 | Upgrade
|
| Other Investing Activities | - | 111.35 | 47.49 | 13.16 | 210.72 | Upgrade
|
| Investing Cash Flow | - | -1,106 | -527.28 | -858.74 | 1,563 | Upgrade
|
| Long-Term Debt Repaid | - | -4.18 | -1.05 | -0.19 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -4.18 | -1.05 | -0.19 | - | Upgrade
|
| Issuance of Common Stock | - | 1,504 | 56.4 | 583.51 | 0.06 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -6,236 | - | Upgrade
|
| Common Dividends Paid | - | -908.44 | - | - | - | Upgrade
|
| Dividends Paid | - | -908.44 | - | -367.46 | -2,550 | Upgrade
|
| Other Financing Activities | - | -7.97 | -3.54 | -11.67 | -68.62 | Upgrade
|
| Financing Cash Flow | - | 582.95 | 51.81 | -5,790 | 4,476 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 8.18 | 1.09 | -55.18 | 3.98 | Upgrade
|
| Net Cash Flow | - | 1,526 | 1,173 | -5,772 | 6,735 | Upgrade
|
| Free Cash Flow | - | 1,794 | 1,421 | 778.97 | 617.4 | Upgrade
|
| Free Cash Flow Growth | - | 26.27% | 82.44% | 26.17% | -18.62% | Upgrade
|
| Free Cash Flow Margin | - | 32.40% | 40.33% | 32.95% | 39.77% | Upgrade
|
| Free Cash Flow Per Share | - | 1.79 | 1.45 | 0.76 | 0.62 | Upgrade
|
| Cash Income Tax Paid | - | 385 | 205.76 | 172.7 | 218.26 | Upgrade
|
| Levered Free Cash Flow | - | 1,442 | 1,057 | -6,104 | 5,352 | Upgrade
|
| Unlevered Free Cash Flow | - | 1,442 | 1,057 | -6,104 | 5,352 | Upgrade
|
| Change in Working Capital | - | -26.24 | 127.81 | -131.67 | -57.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.